BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28332308)

  • 21. Tumor suppressor carcinoembryonic antigen-related cell adhesion molecule 1 potentates the anchorage-independent growth of human hepatoma HepG2 cells.
    Hokari M; Matsuda Y; Wakai T; Shirai Y; Sato M; Tsuchiya A; Takamura M; Yamagiwa S; Suzuki K; Ohkoshi S; Ichida T; Kawachi H; Aoyagi Y
    Life Sci; 2007 Jul; 81(4):336-45. PubMed ID: 17612570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of CEACAM1 isoforms in an in vivo model of mammary morphogenesis: mutational analysis of the cytoplasmic domain of CEACAM1-4S reveals key residues involved in lumen formation.
    Yokoyama S; Chen CJ; Nguyen T; Shively JE
    Oncogene; 2007 Dec; 26(55):7637-46. PubMed ID: 17546042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The CEACAM1-L glycoprotein associates with the actin cytoskeleton and localizes to cell-cell contact through activation of Rho-like GTPases.
    Sadekova S; Lamarche-Vane N; Li X; Beauchemin N
    Mol Biol Cell; 2000 Jan; 11(1):65-77. PubMed ID: 10637291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The CEACAM1-L Ser503 residue is crucial for inhibition of colon cancer cell tumorigenicity.
    Fournès B; Sadekova S; Turbide C; Létourneau S; Beauchemin N
    Oncogene; 2001 Jan; 20(2):219-30. PubMed ID: 11313949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon regulatory factor 1 and a variant of heterogeneous nuclear ribonucleoprotein L coordinately silence the gene for adhesion protein CEACAM1.
    Dery KJ; Silver C; Yang L; Shively JE
    J Biol Chem; 2018 Jun; 293(24):9277-9291. PubMed ID: 29720400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential roles of RET isoforms in medullary and papillary thyroid carcinomas.
    Lian EY; Maritan SM; Cockburn JG; Kasaian K; Crupi MJ; Hurlbut D; Jones SJ; Wiseman SM; Mulligan LM
    Endocr Relat Cancer; 2017 Jan; 24(1):53-69. PubMed ID: 27872141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of normal and neoplastic human mast cells for expression of CD172a (SIRPalpha), CD47, and SHP-1.
    Florian S; Ghannadan M; Mayerhofer M; Aichberger KJ; Hauswirth AW; Schernthaner GH; Printz D; Fritsch G; Böhm A; Sonneck K; Krauth MT; Müller MR; Sillaber C; Sperr WR; Bühring HJ; Valent P
    J Leukoc Biol; 2005 Jun; 77(6):984-92. PubMed ID: 15784688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential expression of RET isoforms in normal thyroid tissues, papillary and medullary thyroid carcinomas.
    Ramone T; Romei C; Ciampi R; Tacito A; Piaggi P; Torregrossa L; Ugolini C; Elisei R
    Endocrine; 2019 Sep; 65(3):623-629. PubMed ID: 31278686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cell-cell adhesion molecule carcinoembryonic antigen-related cellular adhesion molecule 1 inhibits IL-2 production and proliferation in human T cells by association with Src homology protein-1 and down-regulates IL-2 receptor.
    Chen CJ; Shively JE
    J Immunol; 2004 Mar; 172(6):3544-52. PubMed ID: 15004155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms.
    Nagaishi T; Pao L; Lin SH; Iijima H; Kaser A; Qiao SW; Chen Z; Glickman J; Najjar SM; Nakajima A; Neel BG; Blumberg RS
    Immunity; 2006 Nov; 25(5):769-81. PubMed ID: 17081782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computational analysis of isoform-specific signal regulation by CEACAM1-A cell adhesion molecule expressed in PC12 cells.
    Obrink B; Sawa H; Scheffrahn I; Singer BB; Sigmundsson K; Sundberg U; Heymann R; Beauchemin N; Weng G; Ram P; Iyengar R
    Ann N Y Acad Sci; 2002 Oct; 971():597-607. PubMed ID: 12438192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cell adhesion receptor carcinoembryonic antigen-related cell adhesion molecule 1 regulates nucleocytoplasmic trafficking of DNA polymerase delta-interacting protein 38.
    Klaile E; Müller MM; Kannicht C; Otto W; Singer BB; Reutter W; Obrink B; Lucka L
    J Biol Chem; 2007 Sep; 282(36):26629-40. PubMed ID: 17623671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CEACAM1 dynamics during neisseria gonorrhoeae suppression of CD4+ T lymphocyte activation.
    Lee HS; Ostrowski MA; Gray-Owen SD
    J Immunol; 2008 May; 180(10):6827-35. PubMed ID: 18453603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Impact of CEACAM1 in Node-Negative Ovarian Cancer Patients.
    Oliveira-Ferrer L; Goswami R; Galatenko V; Ding Y; Eylmann K; Legler K; Kürti S; Schmalfeldt B; Milde-Langosch K
    Dis Markers; 2018; 2018():6714287. PubMed ID: 30050594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of allelic variants of the bovine immune regulatory molecule CEACAM1 implies a pathogen-driven evolution.
    Kammerer R; Popp T; Singer BB; Schlender J; Zimmermann W
    Gene; 2004 Sep; 339():99-109. PubMed ID: 15363850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutational analysis of the cytoplasmic domain of CEACAM1-4L in humanized mammary glands reveals key residues involved in lumen formation: stimulation by Thr-457 and inhibition by Ser-461.
    Li C; Chen CJ; Shively JE
    Exp Cell Res; 2009 Apr; 315(7):1225-33. PubMed ID: 19146852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of Siglec-7 results in inhibition of in vitro and in vivo growth of human mast cell leukemia cells.
    Landolina N; Zaffran I; Smiljkovic D; Serrano-Candelas E; Schmiedel D; Friedman S; Arock M; Hartmann K; Pikarsky E; Mandelboim O; Martin M; Valent P; Levi-Schaffer F
    Pharmacol Res; 2020 Aug; 158():104682. PubMed ID: 32035162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fc epsilon receptor I-associated lyn-dependent phosphorylation of Fc gamma receptor IIB during negative regulation of mast cell activation.
    Malbec O; Fong DC; Turner M; Tybulewicz VL; Cambier JC; Fridman WH; Daëron M
    J Immunol; 1998 Feb; 160(4):1647-58. PubMed ID: 9469421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cofilin is a mediator of RET-promoted medullary thyroid carcinoma cell migration, invasion and proliferation.
    Giardino E; Catalano R; Barbieri AM; Treppiedi D; Mangili F; Spada A; Arosio M; Mantovani G; Peverelli E
    Mol Cell Endocrinol; 2019 Sep; 495():110519. PubMed ID: 31352037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CEACAM1 inhibits cell-matrix adhesion and promotes cell migration through regulating the expression of N-cadherin.
    Liu J; Di G; Wu CT; Hu X; Duan H
    Biochem Biophys Res Commun; 2013 Jan; 430(2):598-603. PubMed ID: 23219815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.